What does PHARMACIE DE LA PLACE ALBERT do?

PHARMACIE DE LA PLACE ALBERT is a pharmacy in Vorst. Private Limited, started on 6 December 2018, 1 establishment.

What is the address of PHARMACIE DE LA PLACE ALBERT?

The registered office of PHARMACIE DE LA PLACE ALBERT is located at Albertlaan 17, 1190 Vorst.

Is PHARMACIE DE LA PLACE ALBERT still active?

Yes. According to the CBE (28 September 2026) PHARMACIE DE LA PLACE ALBERT is active, legal situation “Normale toestand”, started on 6 December 2018.

Is PHARMACIE DE LA PLACE ALBERT registered on Peppol?

Yes, PHARMACIE DE LA PLACE ALBERT is registered on the Peppol network with ID 0208:0715561377.

What is the enterprise number of PHARMACIE DE LA PLACE ALBERT?

The enterprise number of PHARMACIE DE LA PLACE ALBERT is BE0715561377.

When was PHARMACIE DE LA PLACE ALBERT founded?

PHARMACIE DE LA PLACE ALBERT was founded on 6 December 2018.

Who are the directors of PHARMACIE DE LA PLACE ALBERT?

According to the 2025 annual accounts, the directors of PHARMACIE DE LA PLACE ALBERT are: NATHALIE VAN HUMBEECK.

Is PHARMACIE DE LA PLACE ALBERT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 December 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE DE LA PLACE ALBERT make in 2025?

PHARMACIE DE LA PLACE ALBERT posted a profit after taxes of € 13,112 in financial year 2025.

What is the revenue of PHARMACIE DE LA PLACE ALBERT?

As a small company, PHARMACIE DE LA PLACE ALBERT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 59,392.

PHARMACIE DE LA PLACE ALBERT (Private Limited) - Vorst

Dossier PHARMACIE DE LA PLACE ALBERT, printed on 28 September 2026 from databakkes.be/en/0715561377/pharmacie-de-la-place-albert. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DE LA PLACE ALBERT from Vorst, company number BE0715561377, closed financial year 2025 with a result of € 13,112 after tax. For that financial year PHARMACIE DE LA PLACE ALBERT recorded a gross margin of € 59,392 and equity of € 100,024. Compared with financial year 2024, the result moved from € 16,669 to € 13,112. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.

What it is worth Healthy

€ 100,024

▼ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 13,112

▼ 21% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 57,269

▲ 24% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 30,250

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 103,017

▼ 20% vs 2024

€ 26,756 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 16,293

▲ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 425

▼ 32% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 89,298 Gross margin 2022: € 89,298 First fiscal year in the series	€ 57,590 Gross margin 2023: € 57,590 ▼ 36% vs 2022 (€ 89,298) Unfavourable step	€ 64,969 Gross margin 2024: € 64,969 ▲ 13% vs 2023 (€ 57,590) Favourable step	€ 59,392 Gross margin 2025: € 59,392 ▼ 9% vs 2024 (€ 64,969) Unfavourable step	▼ 9%
Profit after taxes	€ 36,443 Profit after taxes 2022: € 36,443 First fiscal year in the series	€ 11,373 Profit after taxes 2023: € 11,373 ▼ 69% vs 2022 (€ 36,443) Unfavourable step	€ 16,669 Profit after taxes 2024: € 16,669 ▲ 47% vs 2023 (€ 11,373) Favourable step	€ 13,112 Profit after taxes 2025: € 13,112 ▼ 21% vs 2024 (€ 16,669) Unfavourable step	▼ 21%
Equity	€ 133,870 Equity 2022: € 133,870 First fiscal year in the series	€ 110,243 Equity 2023: € 110,243 ▼ 18% vs 2022 (€ 133,870) Unfavourable step	€ 106,912 Equity 2024: € 106,912 ▼ 3% vs 2023 (€ 110,243) Unfavourable step	€ 100,024 Equity 2025: € 100,024 ▼ 6% vs 2024 (€ 106,912) Unfavourable step	▼ 6%
Total debts	€ 258,311 Total debts 2022: € 258,311 First fiscal year in the series	€ 226,457 Total debts 2023: € 226,457 ▼ 12% vs 2022 (€ 258,311) Favourable step	€ 196,793 Total debts 2024: € 196,793 ▼ 13% vs 2023 (€ 226,457) Favourable step	€ 166,457 Total debts 2025: € 166,457 ▼ 15% vs 2024 (€ 196,793) Favourable step	▼ 15%
Cash	€ 78,359 Cash 2022: € 78,359 First fiscal year in the series	€ 54,707 Cash 2023: € 54,707 ▼ 30% vs 2022 (€ 78,359) Unfavourable step	€ 46,107 Cash 2024: € 46,107 ▼ 16% vs 2023 (€ 54,707) Unfavourable step	€ 57,269 Cash 2025: € 57,269 ▲ 24% vs 2024 (€ 46,107) Favourable step	▲ 24%
Retained profit	€ 43,870 Retained profit 2022: € 43,870 First fiscal year in the series	€ 20,243 Retained profit 2023: € 20,243 ▼ 54% vs 2022 (€ 43,870) Unfavourable step	€ 16,912 Retained profit 2024: € 16,912 ▼ 16% vs 2023 (€ 20,243) Unfavourable step	€ 10,024 Retained profit 2025: € 10,024 ▼ 41% vs 2024 (€ 16,912) Unfavourable step	▼ 41%
Dividend	€ 50,000 Dividend 2022: € 50,000 First fiscal year in the series	€ 35,000 Dividend 2023: € 35,000 ▼ 30% vs 2022 (€ 50,000) Unchanged	€ 20,000 Dividend 2024: € 20,000 ▼ 43% vs 2023 (€ 35,000) Unchanged	€ 20,000 Dividend 2025: € 20,000 Unchanged (€ 20,000) Unchanged
Bank debt	€ 180,572 Bank debt 2022: € 180,572 First fiscal year in the series	€ 155,184 Bank debt 2023: € 155,184 ▼ 14% vs 2022 (€ 180,572) Favourable step	€ 129,335 Bank debt 2024: € 129,335 ▼ 17% vs 2023 (€ 155,184) Favourable step	€ 103,017 Bank debt 2025: € 103,017 ▼ 20% vs 2024 (€ 129,335) Favourable step	▼ 20%
Balance sheet total	€ 392,181 Balance sheet total 2022: € 392,181 First fiscal year in the series	€ 336,700 Balance sheet total 2023: € 336,700 ▼ 14% vs 2022 (€ 392,181) Unchanged	€ 303,705 Balance sheet total 2024: € 303,705 ▼ 10% vs 2023 (€ 336,700) Unchanged	€ 266,481 Balance sheet total 2025: € 266,481 ▼ 12% vs 2024 (€ 303,705) Unchanged	▼ 12%

Key figures of PHARMACIE DE LA PLACE ALBERT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DE LA PLACE ALBERT?

What happened at PHARMACIE DE LA PLACE ALBERT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 16, 2026 New annual accounts for financial year 2025: profit of € 13,112 (▼ 21% vs 2024). Source: NBB ↗
Jan 1, 2019 New establishment in Vorst. KBO
2018 NATHALIE VAN HUMBEECK became a director. NBB
Dec 6, 2018 Start of the company according to the CBE. KBO

In short

From € 36,443 profit in 2022 to € 13,112 profit in 2025.

Paid € 20,280 in corporate taxes since 2022.

Best year ever: 2022, with € 36,443 profit.

Paid out € 125,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE DE LA PLACE ALBERT? We notify you, reason included.

Follow PHARMACIE DE LA PLACE ALBERT

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

NATHALIE VAN HUMBEECK

PHARMACIE DE LA PLACE ALBERT

Behind PHARMACIE DE LA PLACE ALBERT is NATHALIE VAN HUMBEECK.

See the full network in the app

Directors

According to the 2025 annual accounts

NATHALIE VAN HUMBEECK

Administrator-manager

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Albertlaan 17

1190 Vorst

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0715.561.377
VAT number: BE 0715.561.377
Registered office: Albertlaan 17, 1190 Vorst
Names & denominations: PHARMACIE DE LA PLACE ALBERT
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 December 2018
Peppol: Active · Active since 22 May 2024
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗